Charles R. Goulding and Kate Esposito consider how the Chan Zuckerberg Initiative is revolutionizing biotechnology through low-cost 3D bioprinting and advanced cellular research across its three pioneering Biohubs.
Charles R. Goulding and Kate Esposito consider how the Chan Zuckerberg Initiative is revolutionizing biotechnology through low-cost 3D bioprinting and advanced cellular research across its three pioneering Biohubs.